Actualités Achillion Pharmaceuticals Inc - ACHN | Actions NASDAQ

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Amended Statement of Ownership (sc 13g/a)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment...

Amended Statement of Ownership (sc 13g/a)

us00448q2012_020720.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:January 31,

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:January 31,

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:January 31,

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:January 31,

Achillion Shareholders Approve Agreement to be Acquired by Alexion

BLUE BELL, Pa., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a...

Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who...

– 2.4 g/dL mean increase in hemoglobin at 24 weeks –– Reduction in blood transfusions from 34 to 1; and...

Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corpor...

Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and...

European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients...

BLUE BELL, Pa., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a...

Achillion Announces Clearance of Investigational New Drug Application for ACH-5228

BLUE BELL, Pa., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Achillion Pharmaceuticals Inc (ACHN)

Outils de qualité professionnelle, pour des investisseurs individuels.

ACHN Actualités

Statement of Ownership (sc 13g)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

Notice of Effectiveness (effect)

Notice of Effectiveness (effect)

Notice of Effectiveness (effect)

Notice of Effectiveness (effect)

Achillion Shareholders Approve Agreement to be Acquired by Alexion

Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who...

Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corpor...

European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients...

Achillion Announces Clearance of Investigational New Drug Application for ACH-5228

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

BLACK FRIDAY

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Achillion Pharmaceuticals Inc (ACHN) Actualités

Achillion Pharmaceuticals Inc (ACHN)

Outils de qualité professionnelle, pour des investisseurs individuels.

ACHN Actualités

Statement of Ownership (sc 13g)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

Notice of Effectiveness (effect)

Notice of Effectiveness (effect)

Notice of Effectiveness (effect)

Notice of Effectiveness (effect)

Achillion Shareholders Approve Agreement to be Acquired by Alexion

Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who...

Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corpor...

European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients...

Achillion Announces Clearance of Investigational New Drug Application for ACH-5228

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

BLACK FRIDAY

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres